Provider Resources to Support Patients

Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment

Watch this PeerView educational activity, in partnership with ZERO Prostate Cancer, providing insights on the latest evidence backing the use of approved and emerging therapeutics in a variety of settings, paired with practical guidance on individualization of treatment regimens based on patient- and disease-specific factors, team-based management of adverse events, and educational strategies that improve treatment adherence. This activity expires January 2, 2027.

Mission Possible in Prostate Cancer: Leveraging Genomics, Modern Therapeutics, and Individualized Patient Care to Improve Outcomes Across the Disease Spectrum

Watch this educational activity, presented in partnership with PeerView and recorded at the 2025 American Society of Clinical Oncology (ASCO) Meeting, featuring experts Karim Fizazi, MD, PhD; Elena Castro, MD; and Matthew R. Smith, MD, PhD. Learners will hear the most recent evidence supporting clinical decision-making across prostate cancer stages and lines of therapy, along with practical case exercises. This symposium bridges the gap between theory and practice, enabling oncology and urology professionals to rapidly improve performance by developing sound, evidence-based protocols for integrating effective, modern therapeutics into routine patient care. This activity expires June 30, 2026.

Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice

In this on-demand version of an event presented in partnership with PeerView at the 2025 AUA Annual Meeting, an expert faculty panel including Neal D. Shore, MD, FACS; Eleni Efstathiou, MD, PhD; and Stephen Freedland, MD, provides the tools to incorporate modern therapeutics into the care of patients across disease stages. Watch now to learn best practices for identification of biochemically recurrent prostate cancer, implementation of genetic testing, team-based management of AEs, and promoting treatment adherence through patient education. This activity expires May 27, 2026.

Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum

Watch this on-demand session recorded at a live ASCO GU 2025 event, presented in partnership with PeerView. This MasterClass & Practicum activity led by Alicia K. Morgans, MD, MPH, FASCO; Matthew R. Smith, MD, PhD; and Sandy Srinivas, MD, provides learners with the strategies they need to incorporate modern prostate cancer care into practice. The faculty panel pairs a review of the efficacy and safety evidence supporting approved and emerging treatment regimens with discussion of realistic patient cases that illustrate practical approaches for creating individualized treatment plans. This activity expires March 14, 2026.

Shared decision-making for prostate cancer patients

In this interactive patient case video, you’ll meet a 53-year-old man with metastatic castration-resistant prostate cancer (mCRPC) and explore early treatment intensification with a PARPi plus ARPI combination. Along the way, you’ll also discover the SHARE Communication Framework – a simple, five-step approach designed to enhance the quality of your patient interactions and support more collaborative, informed treatment decisions.

The purpose of published guidelines are to provide providers and patients with evidence-based and consensus-based best practices for diagnosing, treating, and managing prostate cancer. The American Urologic Association publishes healthcare provider guidelines for early detection, localized prostate cancer, advanced prostate cancer, and radiotherapy.

In addition, the National Comprehensive Cancer Network (NCCN) Guidelines document evidence-based, consensus-driven management to ensure that all patients receive preventive, diagnostic, treatment, and supportive services that are most likely to lead to optimal outcomes. Patient guidelines are also available through the NCCN.